316 related articles for article (PubMed ID: 3612003)
1. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
Chearanai O; Kachintorn U; Plengvanit U
J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
[No Abstract] [Full Text] [Related]
2. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
Bianchi Porro G; Lazzaroni M; Petrillo M; Ardizzone S; Manzionna G; Caruso I; Montrone F
Aliment Pharmacol Ther; 1998 Apr; 12(4):343-7. PubMed ID: 9690723
[TBL] [Abstract][Full Text] [Related]
3. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
Hamilton I; Worsley BW; O'Connor HJ; Axon AT
Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
[TBL] [Abstract][Full Text] [Related]
4. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
Bergoz R
Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
[TBL] [Abstract][Full Text] [Related]
5. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the efficacy of ranitidine, cimetidine (Asiloc), De-Nol and spirulina in the treatment of gastric and duodenal ulcer].
Fica V; Andronescu D; Olteanu D
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):21-35. PubMed ID: 2884709
[No Abstract] [Full Text] [Related]
7. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
[TBL] [Abstract][Full Text] [Related]
8. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
Koo J; Ho J; Lam SK; Wong J; Ong GB
Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
[TBL] [Abstract][Full Text] [Related]
9. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
[No Abstract] [Full Text] [Related]
10. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.
Bianchi Porro G; Parente F; Lazzaroni M
Gut; 1987 Jul; 28(7):907-11. PubMed ID: 3308650
[TBL] [Abstract][Full Text] [Related]
11. [A multicenter comparative clinical trial of sucralfate and cimetidine in the therapy of gastric and duodenal ulcer].
Falisevac V; Vucelić B; Vrhovac B; Hadzić N; Knezević S; Drobnic M; Svalba-Novak V; Vucemilo M; Satler J; Matko I
Lijec Vjesn; 1985 Jan; 107(1):23-6. PubMed ID: 3881638
[No Abstract] [Full Text] [Related]
12. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
Lane M; Lee S; Tasman-Jones C; Nicholson G
N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
Shreeve DR; Klass HJ; Jones PE
Digestion; 1983; 28(2):96-101. PubMed ID: 6360774
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tri-potassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer.
Cipollini F; Altilia F
Br J Clin Pract; 1987 Apr; 41(4):707-9. PubMed ID: 3689651
[No Abstract] [Full Text] [Related]
15. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
Pop P; Nikkels RE; Thys O; Dorrestein GC
Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of tripotassium dicitratobismuthate and cimetidine in the treatment of gastric ulcer].
Chen SP; Pan GZ
Zhonghua Nei Ke Za Zhi; 1986 Aug; 25(8):456-7, 509. PubMed ID: 3803058
[No Abstract] [Full Text] [Related]
17. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
Dunk AA; Prabhu U; Tobin A; O'Morain C; Mowat NA
Aliment Pharmacol Ther; 1990 Apr; 4(2):157-62. PubMed ID: 2104081
[TBL] [Abstract][Full Text] [Related]
18. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
Martin DF; Hollanders D; May SJ; Ravenscroft MM; Tweedle DE; Miller JP
Lancet; 1981 Jan; 1(8210):7-10. PubMed ID: 6109102
[TBL] [Abstract][Full Text] [Related]
19. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
[TBL] [Abstract][Full Text] [Related]
20. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol).
Hollanders D; Morrissey SM; Mehta J
Br J Clin Pract; 1983 Mar; 37(3):112-4. PubMed ID: 6882629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
